This, along with 95% success in FFS projects and a reduced customer concentration (largest customer share fell from 37% to 24%), shows the business base is broadening
A dual-trigger approach was employed, consisting of combined recombinant hCG (Ovidrel 250 g, Merck Serono S.p.A., Modugno, Italy) and a GnRH agonist (Lupro 2 mg, Nang Kuang Pharmaceutical Co., Ltd., Tainan, Taiwan), when at least one follicle reached a mean diameter of 18 mm
The elimination half-life is approximately 5-6 days in patients with overweight or obesity, and in patients with OSA and obesity
It was the first anti-obesity medication to demonstrate cardiovascular benefit in a dedicated outcomes trial (SELECT, 2023)
To date, however, no studies have specifically assessed this endpoint in migraine populations, highlighting a critical gap in the literature and an opportunity for future clinical trials